Van Berkom & Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.9M | Buy |
|
|||||
|
2025
Q1 | $67.3M | Buy |
|
|||||
|
2024
Q4 | $71.6M | Sell |
|
|||||
|
2024
Q3 | $76.8M | Buy |
|
|||||
|
2024
Q2 | $65.7M | Buy |
|
|||||
|
2024
Q1 | $84.4M | Sell |
|
|||||
|
2023
Q4 | $75.3M | Buy |
|
|||||
|
2023
Q3 | $43.5M | Buy |
|
|||||
|
2023
Q2 | $39.7M | Sell |
|
|||||
|
2023
Q1 | $38.5M | Buy |
|
|||||
|
2022
Q4 | $39.2M | Buy |
|
|||||
|
2022
Q3 | $35.4M | Sell |
|
|||||
|
2022
Q2 | $42.6M | Sell |
|
|||||
|
2022
Q1 | $57.2M | Sell |
|
|||||
|
2021
Q4 | $83.6M | Sell |
|
|||||
|
2021
Q3 | $94M | Sell |
|
|||||
|
2021
Q2 | $127M | Sell |
|
|||||
|
2021
Q1 | $147M | Sell |
|
|||||
|
2020
Q4 | $135M | Sell |
|
|||||
|
2020
Q3 | $123M | Sell |
|
|||||
|
2020
Q2 | $116M | Sell |
|
|||||
|
2020
Q1 | $88.8M | Buy |
|
|||||
|
2019
Q4 | $89.2M | Buy |
|
|||||
|
2019
Q3 | $77.2K | Buy |
|
|||||
|
2019
Q2 | $81.5M | Sell |
|
|||||
|
2019
Q1 | $83.6M | Sell |
|
|||||
|
2018
Q4 | $66.1M | Sell |
|
|||||
|
2018
Q3 | $81.3M | Sell |
|
|||||
|
2018
Q2 | $69.3M | Buy |
|
|||||
|
2018
Q1 | $65.4M | Buy |
|
|||||
|
2017
Q4 | $64.5M | Sell |
|
|||||
|
2017
Q3 | $70.4M | Sell |
|
|||||
|
2017
Q2 | $77.7M | Buy |
|
|||||
|
2017
Q1 | $68.8M | Sell |
|
|||||
|
2016
Q4 | $62.3M | Buy |
|
|||||
|
2016
Q3 | $58M | Buy |
|
|||||
|
2016
Q2 | $54.6M | Sell |
|
|||||
|
2016
Q1 | $51.9M | Sell |
|
|||||
|
2015
Q4 | $57.8M | Buy |
|
|||||
|
2015
Q3 | $43.5M | Buy |
|
|||||
|
2015
Q2 | $40.6M | Sell |
|
|||||
|
2015
Q1 | $46.8M | Sell |
|
|||||
|
2014
Q4 | $47.2M | Sell |
|
|||||
|
2014
Q3 | $48.2M | Buy |
|
|||||
|
2014
Q2 | $38.3M | Buy |
|
|||||
|
2014
Q1 | $38.6M | Sell |
|
|||||
|
2013
Q4 | $43.1M | Buy |
|
|||||
|
2013
Q3 | $33.7M | Sell |
|
|||||
|
2013
Q2 | $32.1M | Buy |
|